Cunesoft

Munchen, Germany Founded: 2013 • Age: 13 yrs Acquired By Phlexglobal
Cloud-based regulatory software solutions

About Cunesoft

Cunesoft is a Healthcare company based in Munchen (Germany) founded in 2013, and was acquired by Phlexglobal in January 2020. Cloud-based regulatory software solutions. Cunesoft offers products and services including PhlexTMF V21, TMF Quality Review, and TMF Heatmaps. Its focus areas include HealthTech, Life Sciences Tech, GRC Solutions and Diversified. Its legal entity is Cunesoft GmbH.

Company details

Cunesoft was founded in 2013 in Munich, Germany. SaaS-based regulatory software solutions are supplied to the pharmaceutical and life sciences sectors. Compliance with GxP, 21 CFR Part 11, and Annex 11 standards is maintained, while customization to ICH guidelines is supported. Key offerings include eCTD formatting, electronic submissions, conformity assessments, and the preparation and editing of documentation for chemical, pharmaceutical, and biological submissions.

Key Metrics

Products & Services of Cunesoft

Cunesoft offers a comprehensive portfolio of products and services, including PhlexTMF V21, TMF Quality Review, and TMF Heatmaps.

PhlexTMF V21
eTMF Software

Software for managing clinical trial documents and ensuring compliance.

TMF Quality Review
Consulting Services

Assessment of TMF quality for inspection readiness.

TMF Heatmaps
Analytical Tools

Identifies risks in TMF for targeted improvements.

Apps and channels of Cunesoft

its YouTube channel Phlexglobal - a Cencora PharmaLex company has 336 subscribers and 30 videos.

Phlexglobal - a Cencora PharmaLex company
YouTube 336 subscribers 30 videos Science & Technology
Open channel

Videos from Cunesoft

The most watched videos on Cunesoft's YouTube channel, Phlexglobal - a Cencora PharmaLex company (336 subscribers). Click a video to play it here.

Innovative Trial Master File Management PhlexTMF Software Overview - Advanced eTMF Solution
2.7K views
A Complete Submission Publishing Solution for Life Sciences 2022 Demo
1.2K views
Trial Master File (TMF) Quality Review: Identify and Mitigate Compliance Risk with PhlexTMF
1K views
How AI can prevent TMF document upload errors: Watch the 2-minute video
868 views

More on Phlexglobal - a Cencora PharmaLex company.

Funding Insights of Cunesoft

  • Total Rounds 2
  • Investors Count 3

All 2 funding rounds of Cunesoft with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2016Series A–OCCIDENT – The Science Investor.
Oct 2014Seed–Bayern Kapital, HTGF
–
Valuation history

4 investors in total: 4 institutional.

Investors in Cunesoft

Cunesoft has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Phlexglobal, Bayern Kapital and OCCIDENT.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
High-tech industries are targeted for investments by Bayern Kapital.
bayernkapital.deLandshut, Germany
Venture capital investments are provided to deep-tech startups.
occident.groupMunich, Germany
Early-stage investments are made in high-tech startups by HTGF.
htgf.deBonn, Germany
Clinical trial documents are managed via eTMF systems and services.
1997phlexglobal.comAmersham, United Kingdom
Premium access

Investor details for Cunesoft

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Cunesoft

4 dated milestones of Cunesoft across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded Cunesoft is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Series A,.
  4. Exit Acquired by Phlexglobal.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Cunesoft

Premium access

Complete news archive for Cunesoft

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Cunesoft

Cunesoft was founded in 2013 and raised its 1st funding round 1 year after it was founded.

Cunesoft is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.

Cunesoft was founded in 2013 in Munich, Germany. SaaS-based regulatory software solutions are supplied to the pharmaceutical and life sciences sectors. Compliance with GxP, 21 CFR Part 11, and Annex 11 standards is maintained, while customization to ICH guidelines is supported. Key offerings include eCTD formatting, electronic submissions, conformity assessments, and the preparation and editing of documentation for chemical, pharmaceutical, and biological submissions.

Cunesoft offers PhlexTMF V21, TMF Quality Review, and TMF Heatmaps.

Cunesoft has 4 investors. Key investors include Phlexglobal, Bayern Kapital, OCCIDENT, and High-Tech Gründerfonds.

Cunesoft operates through Cunesoft Gmbh.

Yes. Cunesoft was acquired by Phlexglobal in January 2020.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available